Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers.
Yang Q, Qin T, An T, Wu H, Xu G, Xiang J, Lei K, Zhang S, Xia J, Su G, Wang D, Xue M, Kong L, Zhang W, Wu S, Li Y.
Yang Q, et al. Among authors: li y.
Eur J Pharmacol. 2023 Apr 15;945:175628. doi: 10.1016/j.ejphar.2023.175628. Epub 2023 Feb 28.
Eur J Pharmacol. 2023.
PMID: 36858339